404 related articles for article (PubMed ID: 23894559)
1. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
2. Novel antilithiatic cationic proteins from human calcium oxalate renal stone matrix identified by MALDI-TOF-MS endowed with cytoprotective potential: an insight into the molecular mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
Clin Chim Acta; 2013 Jan; 415():181-90. PubMed ID: 23123287
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
Priyadarshini ; Singh SK; Tandon C
Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in Urolithiasis.
Mittal A; Tandon S; Singla SK; Tandon C
PLoS One; 2016; 11(9):e0162600. PubMed ID: 27649531
[TBL] [Abstract][Full Text] [Related]
5. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
Aggarwal KP; Tandon S; Singh SK; Tandon C
Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
[TBL] [Abstract][Full Text] [Related]
6. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
7. Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis.
Aggarwal S; Tandon C; Forouzandeh M; Singla SK; Kiran R; Jethi RK
Indian J Biochem Biophys; 2005 Apr; 42(2):113-7. PubMed ID: 23923571
[TBL] [Abstract][Full Text] [Related]
8. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
9. Human kidney stone matrix proteins alleviate hyperoxaluria induced renal stress by targeting cell-crystal interactions.
Narula S; Tandon S; Kumar D; Varshney S; Adlakha K; Sengupta S; Singh SK; Tandon C
Life Sci; 2020 Dec; 262():118498. PubMed ID: 32991878
[TBL] [Abstract][Full Text] [Related]
10. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.
Chutipongtanate S; Nakagawa Y; Sritippayawan S; Pittayamateekul J; Parichatikanond P; Westley BR; May FE; Malasit P; Thongboonkerd V
J Clin Invest; 2005 Dec; 115(12):3613-22. PubMed ID: 16308573
[TBL] [Abstract][Full Text] [Related]
11. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
12. Effect of biomolecules from human renal matrix of calcium oxalate monohydrate (CaOx) stones on in vitro calcium phosphate crystallization.
Pathak P; Singh SK; Tandon C
Int Braz J Urol; 2010; 36(5):621-8. PubMed ID: 21044380
[TBL] [Abstract][Full Text] [Related]
13. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
14. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
[TBL] [Abstract][Full Text] [Related]
15. Mass spectroscopic characteristics of low molecular weight proteins extracted from calcium oxalate stones: preliminary study.
Chen WC; Lai CC; Tsai Y; Lin WY; Tsai FJ
J Clin Lab Anal; 2008; 22(1):77-85. PubMed ID: 18200570
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.
Khamchun S; Sueksakit K; Chaiyarit S; Thongboonkerd V
J Biol Inorg Chem; 2019 Mar; 24(2):235-246. PubMed ID: 30701361
[TBL] [Abstract][Full Text] [Related]
18. Oxalate-Degrading Bacillus subtilis Mitigates Urolithiasis in a Drosophila melanogaster Model.
Al KF; Daisley BA; Chanyi RM; Bjazevic J; Razvi H; Reid G; Burton JP
mSphere; 2020 Sep; 5(5):. PubMed ID: 32907948
[TBL] [Abstract][Full Text] [Related]
19. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
Li S; Macaringue EGJ; Zhou D; Shi P; Tang W; Gong J
J Ethnopharmacol; 2022 Feb; 284():114733. PubMed ID: 34644589
[TBL] [Abstract][Full Text] [Related]
20. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis.
More-Krong P; Tubsaeng P; Madared N; Srisa-Art M; Insin N; Leeladee P; Boonla C
Sci Rep; 2020 May; 10(1):8334. PubMed ID: 32433482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
